Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>The <it>enhancer of zeste homolog 2 </it>(<it>EZH2</it>) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with re...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2010-10-01
|
| Reeks: | BMC Cancer |
| Online toegang: | http://www.biomedcentral.com/1471-2407/10/524 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|